Public Company

Yumanity Therapeutics, Inc.

About

Yumanity is a biopharmaceutical company specifically focused on discovering and developing innovative novel therapies to treat devastating neurodegenerative diseases with a critical unmet need. Target conditions include large or orphan disease markets, such as Parkinson’s disease, dementia with Lewy bodies, multiple system atrophy, or MSA, amyotrophic lateral sclerosis, or ALS, and frontotemporal lobar dementia, or FTLD.

Overview

Founded 2014
Type Public
Location Boston, Massachusetts, USA

Stock

YMTX $1.87 -1.06% $(0.02)

Latest News

Why Planet Labs Shares Are Trading Higher; Here Are 28 Stocks Moving Premarket Dec 15, 2022 Benzinga Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares rose 74.7% to $0.4104 in pre-market trading after declining 4% on Wednesday. Surrozen, Inc. (NASDAQ: SRZN) shares rose...
Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 49 Stocks Moving In Wednesday's Mid-Day Session Dec 14, 2022 Benzinga Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of...
Dow Surges Over 100 Points; Charter Communications Shares Slide Dec 14, 2022 Benzinga U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 100 points on Wednesday The Dow traded up 0.42% to 34,252.62 while...
US Stocks Higher Ahead Of Fed Decision Dec 14, 2022 Benzinga U.S. stocks traded higher this morning, with the Dow Jones gaining over 80 points on Wednesday Following the market opening Wednesday, the Dow traded up...
Why Vallon Pharmaceuticals Shares Are Trading Higher By Over 150%; Here Are 29 Stocks Moving Premarket Dec 14, 2022 Benzinga Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares rose 150.9% to $0.6313 in pre-market trading after the company entered into a definitive merger agreement with GRI...